乌拉地尔配合腔内修复术治疗Stanford B型胸主动脉夹层动脉瘤的临床疗效分析

发布时间：2018-02-26 10:28

本文关键词： 胸主动脉夹层动脉瘤腔内修复术乌拉地尔　出处：《实用癌症杂志》2016年12期 　论文类型：期刊论文

【摘要】：目的探讨乌拉地尔配合腔内修复术治疗Stanford B型胸主动脉夹层动脉瘤的临床效果。方法选取Stanford B型胸主动脉夹层动脉瘤患者37例,经主动脉CT血管造影(CTA)确诊后,对患者行胸主动脉夹层腔内修复术,手术前、中以及后期均采用乌拉地尔配合控制术中血压。结果 37例手术均成功完成,手术成功率100%。术后随访1年,其中术后2个月因再发胸主动脉夹层动脉瘤死亡1例,术后6个月因腹主动脉夹层而接受外科手术1例,其余患者预后状态良好,随访1年患者的存活率为97.3%。结论稳定的血压结合精准的腔内修复是治疗Stanford B型胸主动脉夹层动脉瘤成功的关健。采用乌拉地尔配合腔内修复术治疗Stanford B型胸主动脉夹层动脉瘤安全、有效,值得临床进一步推广。
[Abstract]:Objective to investigate the clinical effect of urapidil combined with endovascular repair in the treatment of Stanford B type thoracic aortic dissection aneurysm. Methods 37 patients with Stanford B thoracic aortic dissection aneurysm were diagnosed by CT angiography. Endovascular repair of thoracic aortic dissection was performed. Urapidil was used to control intraoperative blood pressure before, during and after operation. Results all 37 cases were successfully operated, and the success rate was 100%. All patients were followed up for 1 year. One patient died of recurrent thoracic aortic dissection 2 months after operation, and one underwent surgical operation for abdominal aortic dissection 6 months after operation. The prognosis of the remaining patients was good. Conclusion stable blood pressure combined with accurate endovascular repair is the key to the successful treatment of Stanford B thoracic aortic dissection aneurysm. Urapidil combined with endovascular repair is used to treat Stanford B thoracic active thoracic aneurysm. Vein dissecting aneurysm is safe, Effective, worthy of further clinical promotion.
【作者单位】：江苏省泰州市第二人民医院;
【分类号】：R654.3

【相似文献】